If people here wish to see further indications that TNFerade works in other cancers, follow this thread to what's recently been reported in Esophageal Cancer.
There is almost no doubt that approval of TNFerade is delayed because of the failed PACT Trial, but anyone convinced it will be denied over time will miss the boat. Like DNDN, Provenge approval was delayed, but not denied. How many here followed D.D.'s recommendations and didn't invest when it was well below $10. Some really wise investors on that one now have ten bangers, I admit, I wasn't one, but then I failed to make the right decision, I didn't let someone tell me what to decide.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.